244 related articles for article (PubMed ID: 20308613)
1. Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding.
Hagedorn I; Schmidbauer S; Pleines I; Kleinschnitz C; Kronthaler U; Stoll G; Dickneite G; Nieswandt B
Circulation; 2010 Apr; 121(13):1510-7. PubMed ID: 20308613
[TBL] [Abstract][Full Text] [Related]
2. FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis.
May F; Krupka J; Fries M; Thielmann I; Pragst I; Weimer T; Panousis C; Nieswandt B; Stoll G; Dickneite G; Schulte S; Nolte MW
Br J Haematol; 2016 Jun; 173(5):769-78. PubMed ID: 27018425
[TBL] [Abstract][Full Text] [Related]
3. Factor XIIa inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic benefit.
Xu Y; Cai TQ; Castriota G; Zhou Y; Hoos L; Jochnowitz N; Loewrigkeit C; Cook JA; Wickham A; Metzger JM; Ogletree ML; Seiffert DA; Chen Z
Thromb Haemost; 2014 Apr; 111(4):694-704. PubMed ID: 24336918
[TBL] [Abstract][Full Text] [Related]
4. The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats.
Krupka J; May F; Weimer T; Pragst I; Kleinschnitz C; Stoll G; Panousis C; Dickneite G; Nolte MW
PLoS One; 2016; 11(1):e0146783. PubMed ID: 26815580
[TBL] [Abstract][Full Text] [Related]
5. Selective factor XIIa inhibition attenuates silent brain ischemia: application of molecular imaging targeting coagulation pathway.
Chen JW; Figueiredo JL; Wojtkiewicz GR; Siegel C; Iwamoto Y; Kim DE; Nolte MW; Dickneite G; Weissleder R; Nahrendorf M
JACC Cardiovasc Imaging; 2012 Nov; 5(11):1127-38. PubMed ID: 23153913
[TBL] [Abstract][Full Text] [Related]
6. Defective thrombus formation in mice lacking coagulation factor XII.
Renné T; Pozgajová M; Grüner S; Schuh K; Pauer HU; Burfeind P; Gailani D; Nieswandt B
J Exp Med; 2005 Jul; 202(2):271-81. PubMed ID: 16009717
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic pathway of coagulation and arterial thrombosis.
Gailani D; Renné T
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
[TBL] [Abstract][Full Text] [Related]
8. Factor XIIa as a Novel Target for Thrombosis: Target Engagement Requirement and Efficacy in a Rabbit Model of Microembolic Signals.
Barbieri CM; Wang X; Wu W; Zhou X; Ogawa AM; O'Neill K; Chu D; Castriota G; Seiffert DA; Gutstein DE; Chen Z
J Pharmacol Exp Ther; 2017 Mar; 360(3):466-475. PubMed ID: 28035006
[TBL] [Abstract][Full Text] [Related]
9. Targeting coagulation factor XII as a novel therapeutic option in brain trauma.
Hopp S; Albert-Weissenberger C; Mencl S; Bieber M; Schuhmann MK; Stetter C; Nieswandt B; Schmidt PM; Monoranu CM; Alafuzoff I; Marklund N; Nolte MW; Sirén AL; Kleinschnitz C
Ann Neurol; 2016 Jun; 79(6):970-82. PubMed ID: 27043916
[TBL] [Abstract][Full Text] [Related]
10. The full-length cDNA of anticoagulant protein infestin revealed a novel releasable Kazal domain, a neutrophil elastase inhibitor lacking anticoagulant activity.
Lovato DV; Nicolau de Campos IT; Amino R; Tanaka AS
Biochimie; 2006 Jun; 88(6):673-81. PubMed ID: 16469426
[TBL] [Abstract][Full Text] [Related]
11. The intrinsic pathway of coagulation is essential for thrombus stability in mice.
Renné T; Nieswandt B; Gailani D
Blood Cells Mol Dis; 2006; 36(2):148-51. PubMed ID: 16466946
[TBL] [Abstract][Full Text] [Related]
12. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a novel factor XIIa inhibitor in the hematophagous insect, Triatoma infestans (Hemiptera: Reduviidae).
Campos IT; Tanaka-Azevedo AM; Tanaka AS
FEBS Lett; 2004 Nov; 577(3):512-6. PubMed ID: 15556638
[TBL] [Abstract][Full Text] [Related]
14. The Kazal-type inhibitors infestins 1 and 4 differ in specificity but are similar in three-dimensional structure.
Campos IT; Souza TA; Torquato RJ; De Marco R; Tanaka-Azevedo AM; Tanaka AS; Barbosa JA
Acta Crystallogr D Biol Crystallogr; 2012 Jun; 68(Pt 6):695-702. PubMed ID: 22683792
[TBL] [Abstract][Full Text] [Related]
15. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
[TBL] [Abstract][Full Text] [Related]
16. Alleviation of secondary brain injury, posttraumatic inflammation, and brain edema formation by inhibition of factor XIIa.
Hopp S; Nolte MW; Stetter C; Kleinschnitz C; Sirén AL; Albert-Weissenberger C
J Neuroinflammation; 2017 Feb; 14(1):39. PubMed ID: 28219400
[TBL] [Abstract][Full Text] [Related]
17. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
18. Novel roles for factor XII-driven plasma contact activation system.
Müller F; Renné T
Curr Opin Hematol; 2008 Sep; 15(5):516-21. PubMed ID: 18695377
[TBL] [Abstract][Full Text] [Related]
19. Role of Factor XII in hemostasis and thrombosis: clinical implications.
Renné T; Gailani D
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):733-41. PubMed ID: 17605651
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke--brief report.
Stegner D; Thielmann I; Kraft P; Frohman MA; Stoll G; Nieswandt B
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2212-7. PubMed ID: 23868933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
